Delivery Order SPE2DR25D2108-SPE2DR26F6RB5
- Not listed
- The Defense Logistics Agency awarded a $36,275.25 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 9, 2025. This competitive award, issued on December 8, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a $16,924.96 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with final delivery due by December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, and the work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under the company's existing contract vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $9,099.77 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 13, 2025, with completion scheduled for November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small single-transaction order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a $3,267.57 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a $8,634.89 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order, issued on October 30, 2025, supports the federal government's pharmaceutical supply needs through a competitive procurement process with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a $69,558.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers....
- The Defense Logistics Agency awarded a delivery order valued at $22,421.56 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol in patients at risk...
- The Defense Logistics Agency awarded a delivery order valued at $21,787.79 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a direct purchase under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication...
- The Defense Logistics Agency awarded a $1,926.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of June 24, 2025. This non-set-aside contract utilizes competitive procurement procedures and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RB5Delivery Order
The Defense Logistics Agency awarded a $27,169.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed price, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Repatha, a high-cost cardiovascular medication, represents one of many specialty pharmaceutical products delivered through this strategic contract arrangement serving the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 11/23/25 |